Breakthroughs in Targeted In Vivo Gene Editing

Breakthroughs in Targeted In Vivo Gene Editing is organized by American Society of Gene & Cell Therapy (ASGCT) and will be held from Nov 20 - 21, 2025 at Marriott Marquis San Diego Marina, San Diego, California, United States of America.

Description:
This 1.5-day event will bring together leading researchers and clinicians to engage with pioneering science and shape the future of gene editing delivery in vivo. In addition, you’ll build connections with experts and peers in an intimate environment designed to foster learning, collaboration, and meaningful connections.

Dedicated to cutting-edge solutions for targeted delivery, this event is your chance to engage with pioneering research, overcome tissue-specific challenges, and shape the future of medicine by driving the field of gene editing forward.

• Discover Cutting-Edge Solutions: Delve into advanced strategies for targeted delivery to key tissue types, including HSCs, the liver, CNS, muscle, and immune cells.
• Gain Translational Insights: Learn from real-world lessons and emerging technologies that can directly inform your research and accelerate your work from the lab to the clinic.
• Connect and Collaborate: Build meaningful connections with top researchers and clinicians in an intimate environment designed for knowledge exchange and networking.

Goals + Takeaways:
The goals of this conference are to:

• Highlight cutting-edge scientific and clinical advancements in the delivery of gene editing in vivo, focusing on challenges and topics relevant to academic researchers in basic science 
• Foster knowledge exchange, collaboration, and networking through scientific presentations, abstracts/poster sessions, and informal discussions

By the end of this conference, you’ll walk away with:

• A deeper understanding of how in vivo gene editing delivery is advancing across key tissue types (HSCs, liver, CNS, muscle, and immune cells), and lessons learned from progress
• Insights into how researchers are overcoming tissue-specific delivery challenges
• Emerging strategies to boost targeted gene editing efficiency, specificity, and durability in vivo
• Lessons from the translational pipeline that can inform your research
• New opportunities for collaboration and cross-disciplinary exchange